Prognosis Assessment

Age (years)

PSA Level (ng/mL)

Gleason Score Select score 6 7 (3+4) 8 (4+4) 9 (4+5) 10 (5+5)

Number of Metastatic Sites Select number 1 site 2 sites 3+ sites

Bone Metastases Select status None Limited (<6 sites) Extensive (≥6 sites)

Visceral Metastases Select status None Present

ECOG Performance Status Select status 0 - Fully active 1 - Restricted but ambulatory 2 - Ambulatory but unable to work 3 - Limited self-care 4 - Completely disabled

Hemoglobin (g/dL)

Alkaline Phosphatase (U/L)

LDH (U/L)

Calculate Prognosis Reset

About Prognosis Assessment

This calculator uses validated prognostic factors to estimate survival in metastatic prostate cancer.

Risk Categories:

• Low Risk: >30 months
• Intermediate Risk: 18-30 months
• High Risk: <18 months

Gleason Score:

• • 6: Well differentiated
• • 7: Moderately differentiated
• • 8-10: Poorly differentiated

Metastatic Sites:

• • Bone (most common)
• • Lymph nodes
• • Liver
• • Lung
• • Brain

Performance Status:

• • 0: Fully active
• • 1: Restricted but ambulatory
• • 2: Ambulatory but unable to work
• • 3: Limited self-care
• • 4: Completely disabled

Limitations:

• • Population-based estimates
• • Individual variation exists
• • Treatment advances not captured
• • Comorbidities not considered

Professional Resources:

• • Medical oncologist
• • Urologist
• • Radiation oncologist